160214-63-1
160214-63-1
Chemical Structure
HBV Seq2 aa:208-216
- CAS No.: 160214-63-1
- Formula:C52H85N9O11
- Molecular Weight:1012.29
InChIKey: WEHXZULNFUKNDJ-MJNVZNKNSA-N
SMILES: CC(C)C[C@@H](C(O)=O)NC([C@H](CC(C)C)NC([C@H]1N(CCC1)C([C@H](CC(C)C)NC([C@H](CC2=CC=CC=C2)NC([C@H]3N(CCC3)C([C@H](CO)NC([C@H](CC(C)C)NC([C@@H](N)[C@@H](C)CC)=O)=O)=O)=O)=O)=O)=O)=O
Biological Activity: HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B virus[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HBV Seq2 aa:208-216 | HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B virus. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
